Tocvan Provides Corporate Update
Tocvan granted 2.75 million stock options to directors, officers and consultants, exercisable at C$0.79 for five years, plus 900,000 restricted share units vesting after 12 months. The equity awards remain subject to Canadian Securities Exchange approval.










